banner USF College of Arts & Sciences A-Z Index CAS USF Search OASIS myUSF

USF Home > College of Arts and Sciences > Technology & Innovation Forum: Nanotechnology

Dr. Scott McNeil

Dr. Scott McNeil serves as the Director of the Nanotechnology Characterization Laboratory (NCL) for SAIC-Frederick and the National Cancer Institute at Frederick (NCI-Frederick), where he coordinates preclinical characterization of nanotech cancer therapeutics and diagnostics. At the NCL, Dr. McNeil leads a team of scientists responsible for testing candidate nanotech drugs and diagnostics, evaluating safety and efficacy, and assisting with product development -- from discovery-level, through scale-up and into clinical trials. NCL has assisted in characterization and evaluation of more than 250 nanotechnology products, several of which are now in human clinical trials. Dr. McNeil is a member of several working groups on nanomedicine, environmental health and safety, and other nanotechnology issues. He is an invited speaker to numerous nanotechnology-related conferences and has several patents pending related to nanotechnology and biotechnology. He also directs SAIC-Frederick’s Imaging and Nanotechnology Group (ING), and is a Vice President of SAIC-Frederick.

Prior to establishing the NCL, he served as a Senior Scientist in the Nanotech Initiatives Division at SAIC where he transitioned basic nanotechnology research to government and commercial markets. He advises Industry and State and US Governments on the development of nanotechnology and is a member of several governmental and industrial working groups related to nanotechnology policy, standardization and commercialization. Dr. McNeil's professional career includes tenure as an Army Officer, with tours as Chief of Biochemistry at Tripler Army Medical Center, and as a Combat Arms officer during the Gulf War. He received his bachelor's degree in chemistry from Portland State University and his doctorate in cell biology from Oregon Health Sciences University.